METHODS We consecutively enrolled AMI patients who underwent percutaneous coronary intervention (PCI) in the COREA-AMI (CardiOvascular Risk and idEntificAtion of potential high-risk population in AMI) registry including nine major university hospitals throughout South Korea from January 2004 to December 2009. OMT was defined as taking all three medications including statin, beta-blocker, and RAS blocker (angiotensin converting enzyme inhibitor or angiotensin receptor blocker) with dual antiplatelet agent (DAPT) at discharge or with one or more antiplatelet agent at 1 year. The primary endpoint was all-cause death and landmark analysis for 1-year post-MI survivors were performed.
RESULTS Of 4,748 AMI patients, 2,517 were taking OMT with DAPT and 1,878 were not taking OMT at discharge. At 1 year, 1,719 were prescribed OMT with one or more antiplatelet 1,845 were not prescribed OMT among 4,200 who were alive at 1 year stably without non-fatal MI or stroke. Median follow-up duration was 43.8 months (interquartile range 29.8 to 60.5 months). Within the first year, the incidence rates of primary endpoint were 2.3% in OMT group and 5.4% in non-OMT group [ BACKGROUND Clinical trials have failed to show a clear benefit of mechanical unloading of the left ventricle (LV) to limit ischemiareperfusion injury (IRI) in acute myocardial infarction (AMI), which may reflect a poor understanding of whether to unload the LV before or after reperfusion. We explored the kinetics of LV unloading with an axial flow catheter (Impella) in relation to balloon reperfusion as a strategy to reduce infarct size and improve survival in AMI.
METHODS
We first employed a swine model of AMI. After 90 minutes of LAD occlusion, adult, male swine (n¼4.group) were randomized to either: 1) 120 minutes of reperfusion alone (IRI), 2) 15, 30, or 60 minutes of LV unloading before 120 minutes of coronary reperfusion (Impella to Balloon Group; ITB-15; ITB-30; ITB-60) or 3) 30 minutes of coronary reperfusion followed by LV unloading and an additional 120 minutes of reperfusion (Balloon to Impella Group; BTI-30). Infarct size, myocardial kinase activity, and mitochondrial integrity were quantified. To begin exploring the clinical utility of LV unloading before reperfusion we retrospectively studied all patients in the USPella registry presenting with acute ST-segment elevation myocardial infarction and cardiogenic shock who received an Impella within 120 minutes before (n¼41; STEMI-ITB) or within 120 minutes after (n¼76; STEMI-BTI) percutaneous coronary reperfusion between 2009 and 2014.
RESULTS Compared to IRI alone, infarct size was reduced in the ITB-30 and ITB-60 groups, but not in the ITB-15 or BTI groups (Figure) . Levels of phosphorylated Akt, Erk-1/2, GSK3b and mitochondria per cardiomyocyte were increased within the infarct zone in the ITB-30 and ITB-60 groups, not the BTI group. In the registry analysis, in-hospital (51% vs 28%, p¼0.02) and 30-day survival (42% vs 20%, p¼0.03) were higher in the STEMI-ITB than the STEMI-BTI group. A STEMI-ITB time of less than 60 minutes (n¼38) was associated with higher in-hospital survival than a STEMI-BTI time of less than 60 minutes (n¼40) (50% vs 25%, p¼0.02). CONCLUSIONS Primary LV unloading with an axial flow catheter for 30 or 60 minutes before, not after, coronary reperfusion is associated with reduced infarct size, increased cardioprotective signaling, and improved mitochondrial integrity. These preclinical findings are supported by improved survival among patients treated with an axial flow catheter before, not after reperfusion. BACKGROUND Routine thrombus aspiration is superior to conventional primary percutaneous coronary intervention (PCI) in terms of improved myocardial perfusion in patients with acute myocardial infarction with ST-segment elevation (STEMI), but its clinical usefulness is still questionable. Myocardial perfusion after thrombus aspiration has not been evaluated by a quantitative index of microcirculatory resistance (IMR) in a randomized fashion.
METHODS We performed a randomized, controlled clinical trial to evaluate impact of manual thrombus aspiration (the Eliminate aspiration catheter, Terumo Medical Supply, Japan) on microcirculatory resistance after primary PCI in 128 patients with the first STEMI randomly assigned to thrombus aspiration or conventional primary PCI group before coronary angiography. The primary endpoint was defined as a mean value of IMRcorr in thrombus aspiration compared to conventional PCI group. Myocardial perfusion grade, resolution of ST-segment elevation, enzymatic infarct size, left ventricle remodeling and rate of adverse cardiac events were secondary endpoints.
RESULTS Manual thrombus aspiration, as compared with conventional PCI, resulted in significantly lower IMR corr (27.5AE16,8 U vs. 39,9AE32,7 U, P ¼ 0,039). Treatment with thrombus aspiration, as compared with conventional PCI, resulted in similar rates of myocardial perfusion grade 0 or 1 (21,5% vs. 28,6%; RR 0,75; 95% CI, 0,41 to 1,38; P¼0,36), complete resolution of ST-segment elevation (61,5% vs. 49,2%; RR 1,25; 95% CI, 0,91 to 1,71, P¼0,16), similar infarct size (median AUC CK-MB: 4362 U/L (IQR: 696 to 15636 U/L) versus 4401 U/L (IQR: 996 to 15657 U/L), p¼0.27), similar median value of WMSI (1,23 vs 1,23), LV sphericity volume index (0,43 vs. 0,41) and similar rate of LV remodeling (27,9 vs 18,5%, p¼0,21) . The rate of major adverse events (death, myocardial infarction, stroke or hospitalization for heart failure) between the groups was similar 4,6% vs, 11,1%, P¼0,20. In a multiple regression model with the log-transformed IMR as dependent variable, after adjusting for clinical, angiographic and procedural variables, thrombus aspiration was not an independent predictor of lower IMR (28.4 U; 95% CI, 24.7 to 32.8 U, vs. 32.4 U; 95% CI, 28.1 to 37.4 U; estimate 0,877, 95%CI 0,715-1,077, P¼0.21). Histopathological examination confirmed successful thrombus aspiration in 89.6% of patients.
CONCLUSIONS Manual thrombus aspiration reduces microcirculatory resistance indicating better myocardial perfusion compared to conventional PCI in patients with STEMI. However, routine manual thrombus aspiration is not an independent predictor of reduced microcirculatory resistance. Reduction in microcirculatory resistance of 12,3% achieved by routine manual aspiration is not sufficient to allow echocardiographic or clinical improvement in STEMI patients at mid-term follow up.
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TCT-246 Impact of thrombus age on efficacy of manual thrombus aspiration: subanalysis form the PATA STEMI trial BACKGROUND The composition of thrombus in infarct-related artery is related to the age of thrombus. It has not been analyzed the impact of thrombus age on the efficacy of manual thrombus aspiration in STEMI patients assessed by invasive and quantitative method of measuring microcirculatory resistance.
METHODS Out of 128 patients randomly allocated to either routine manual thrombus aspiration or standard pPCI, 75 patients underwent thrombus aspiration of which 10 patients had crossover. The efficacy of thrombus aspiration was assessed by determining the index of microcirculatory circulation. The age of thrombus was assessed after hematoxylin eosin staining. Fresh thrombi were rich in erythrocytes with no signs of lysis of nuclei. Lytic thrombi had signs of lysis and cardiohexia, while organized thrombi had thick collagen bands.
RESULTS
In 49 patients thrombus size allowed histologic examination with hematoxillin eosin staining. Fresh thrombus was found in 25 patients and lytic or organized thrombus was found in 24 patients. There were no differences in baseline clinical characteristics between the group with fresh and old thrombi: 59.7AE10.55 vs. 57.9AE13.07, P¼0.6, 76.0 vs. 75.8% male patients, risk factors >2 44.0 vs 16.7%, P¼0.06, patient delay median 45 ) min, P¼0.17, total ischemic time 166 ), P¼0.21, antecedent angina 56.0 vs. 50.0%, P¼0.88, the rate of anterior STEMI 40.0 vs. 29.2%, P¼0.63 and total STsegment deviation 16.2AE8.94 vs. 16.7AE9.91, P¼0.85, respectively. There were no inter-group differences in angiographic and procedural characteristics: multi vessel disease (48.0 vs. 50.0%, P¼0.69), TIMI 0 or 1 at baseline (84 vs. 87.5%, P¼0.72), TIMI 3 after completion of pPCI (96.0 vs 91.7%, P¼0.52), thrombus length (12.3AE8.86 vs. 12.4AE8.12, P¼1) and final MBG 0 or 1 (20.0% vs. 33.3%, P¼0.29). Resolution of ST-segment elevation (80.0 vs. 50.0%, P¼0.027) and IMRcorr (23.2AE13.65 vs. 37.2AE27.32, P¼0.032) were lower in the group with fresh thrombi compared to old thrombi. There was a trend towards lower rate of distal embolizations in the group with fresh thrombi (8.0 vs. 22.9%, P¼0.074). However, there were no differences in infarct size (AUC CK 41542.7AE31052.9 vs. 44712.1AE26186.1, P¼0.71), LVEF (55.2AE11.67 vs. 54.0AE10.63, P¼0.72,) WMSI (1.37AE0.37 vs. 1.29AE0.32) or remodeling rate (28.0 vs. 25.0%, P¼1) between the groups with fresh and old thrombi.
CONCLUSIONS The manual aspiration of fresh thrombi leads to improved myocardial perfusion in STEMI patients as compared with old thrombi. However, we were unable to identify clinical or angiographic characteristics to be associated with fresh thrombi. In addition, improved myocardial perfusion was not associated with improved clinical outcome in patients with fresh compared to old thrombi. BACKGROUND Previous studies have suggested that thyroid dysfunction is associated with the mortality in patients with acute myocardial infarction, but whether the thyroid function status is associated with the prognosis of primary PCI has not been evaluated sufficiently.
METHODS Consecutive 1079 patients with ST-elevation myocardial infarction (STEMI), who were hospitalized in Fuwai hospital from January 2010 to December 2012, were enrolled into this study. All patients underwent primary PCI treatment and thyroid function profile evaluation within the first 12 hours after admission. The duration B96
